Katherine Luden Morrow, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vena Cava Filters | 2 | 2020 | 252 | 1.160 |
Why?
|
Venous Thrombosis | 2 | 2019 | 1239 | 0.660 |
Why?
|
Foreign-Body Migration | 1 | 2019 | 222 | 0.600 |
Why?
|
Vena Cava, Inferior | 1 | 2019 | 440 | 0.560 |
Why?
|
Device Removal | 1 | 2019 | 656 | 0.480 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1206 | 0.480 |
Why?
|
Peripheral Arterial Disease | 2 | 2022 | 1188 | 0.460 |
Why?
|
Catheterization, Peripheral | 1 | 2016 | 345 | 0.440 |
Why?
|
Arterial Occlusive Diseases | 1 | 2016 | 793 | 0.420 |
Why?
|
Thrombectomy | 1 | 2016 | 680 | 0.400 |
Why?
|
Renal Insufficiency | 1 | 2016 | 804 | 0.370 |
Why?
|
Tissue Plasminogen Activator | 1 | 2016 | 1261 | 0.360 |
Why?
|
Vascular Surgical Procedures | 3 | 2021 | 1475 | 0.310 |
Why?
|
Thrombolytic Therapy | 1 | 2016 | 2161 | 0.300 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 2158 | 0.290 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2376 | 0.280 |
Why?
|
Specialties, Surgical | 2 | 2021 | 391 | 0.280 |
Why?
|
Acute Kidney Injury | 1 | 2016 | 1972 | 0.240 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2538 | 0.240 |
Why?
|
Ohio | 3 | 2020 | 337 | 0.220 |
Why?
|
Thrombosis | 1 | 2016 | 2968 | 0.220 |
Why?
|
Personnel Selection | 2 | 2021 | 189 | 0.210 |
Why?
|
Bloodless Medical and Surgical Procedures | 1 | 2021 | 3 | 0.200 |
Why?
|
Hemodilution | 1 | 2021 | 114 | 0.190 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2023 | 1390 | 0.190 |
Why?
|
Kidney | 1 | 2016 | 7186 | 0.190 |
Why?
|
Graft Occlusion, Vascular | 1 | 2023 | 549 | 0.170 |
Why?
|
Computer-Assisted Instruction | 1 | 2020 | 365 | 0.150 |
Why?
|
Iliac Artery | 1 | 2018 | 364 | 0.150 |
Why?
|
Angiography, Digital Subtraction | 1 | 2017 | 341 | 0.140 |
Why?
|
Perfusion Imaging | 1 | 2017 | 195 | 0.130 |
Why?
|
Suture Techniques | 1 | 2020 | 798 | 0.130 |
Why?
|
Video Recording | 1 | 2020 | 949 | 0.130 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2018 | 277 | 0.130 |
Why?
|
Career Choice | 1 | 2021 | 744 | 0.130 |
Why?
|
Endarterectomy, Carotid | 1 | 2020 | 546 | 0.120 |
Why?
|
Carotid Artery, Internal | 1 | 2017 | 445 | 0.120 |
Why?
|
Blood Transfusion | 1 | 2021 | 1301 | 0.120 |
Why?
|
Drainage | 1 | 2020 | 1142 | 0.120 |
Why?
|
Aortic Aneurysm | 1 | 2018 | 643 | 0.120 |
Why?
|
Veins | 1 | 2018 | 770 | 0.120 |
Why?
|
Blood Vessel Prosthesis | 1 | 2018 | 933 | 0.120 |
Why?
|
Treatment Failure | 1 | 2019 | 2618 | 0.110 |
Why?
|
Carotid Artery Diseases | 1 | 2020 | 882 | 0.110 |
Why?
|
Upper Extremity | 1 | 2018 | 648 | 0.110 |
Why?
|
Risk Assessment | 6 | 2021 | 23338 | 0.110 |
Why?
|
Vascular Patency | 3 | 2023 | 886 | 0.110 |
Why?
|
Time Factors | 6 | 2021 | 40075 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2021 | 1186 | 0.100 |
Why?
|
Education, Medical, Undergraduate | 1 | 2020 | 1008 | 0.100 |
Why?
|
Internship and Residency | 2 | 2021 | 5788 | 0.100 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3508 | 0.090 |
Why?
|
Risk Factors | 8 | 2023 | 72290 | 0.090 |
Why?
|
Carotid Stenosis | 1 | 2017 | 854 | 0.090 |
Why?
|
Lower Extremity | 1 | 2017 | 1158 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2170 | 0.080 |
Why?
|
Renal Dialysis | 1 | 2018 | 1786 | 0.080 |
Why?
|
Retrospective Studies | 8 | 2023 | 77449 | 0.080 |
Why?
|
Students, Medical | 1 | 2021 | 1862 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12245 | 0.070 |
Why?
|
Mentors | 2 | 2021 | 631 | 0.070 |
Why?
|
Treatment Outcome | 7 | 2023 | 63114 | 0.060 |
Why?
|
Endovascular Procedures | 1 | 2018 | 1979 | 0.060 |
Why?
|
Clinical Competence | 1 | 2020 | 4687 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4215 | 0.060 |
Why?
|
Aged | 8 | 2021 | 163280 | 0.060 |
Why?
|
Humans | 14 | 2023 | 744343 | 0.050 |
Why?
|
Male | 11 | 2021 | 350118 | 0.050 |
Why?
|
Middle Aged | 7 | 2021 | 213383 | 0.050 |
Why?
|
Colloids | 1 | 2021 | 136 | 0.050 |
Why?
|
Female | 11 | 2021 | 380194 | 0.050 |
Why?
|
Stroke | 2 | 2020 | 9981 | 0.040 |
Why?
|
Self-Assessment | 1 | 2020 | 390 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2018 | 57776 | 0.040 |
Why?
|
Angiography | 1 | 2023 | 1639 | 0.040 |
Why?
|
Length of Stay | 2 | 2021 | 6309 | 0.040 |
Why?
|
Ankle Brachial Index | 1 | 2017 | 154 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2020 | 413 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1127 | 0.030 |
Why?
|
Travel | 1 | 2021 | 788 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 857 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 551 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1525 | 0.030 |
Why?
|
Educational Measurement | 1 | 2020 | 1210 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1654 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 7729 | 0.030 |
Why?
|
Adult | 4 | 2021 | 214055 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2018 | 2110 | 0.030 |
Why?
|
Motivation | 1 | 2021 | 1971 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2508 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1781 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4201 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10397 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3749 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5952 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2759 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2018 | 15295 | 0.020 |
Why?
|
Registries | 1 | 2020 | 8089 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3327 | 0.010 |
Why?
|
Health Care Costs | 1 | 2017 | 3209 | 0.010 |
Why?
|
Software | 1 | 2017 | 4443 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15076 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8388 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15540 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29063 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 53288 | 0.010 |
Why?
|